EconomyMarkets

European shares start week on firm footing, vaccine developments eyed By Reuters

© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt

(Reuters) – European shares rebounded on Monday after a Wall Street-led rout in technology stocks kept global sentiment subdued in the previous week, with investors keeping a close watch on COVID-19 vaccine developments.

Australia expects to receive its first batches of a potential COVID-19 vaccine in January after a deal was struck with CSL (AX:) to manufacture two vaccines – one developed by rival AstraZeneca (L:) and Oxford University, and another in CSL’s own labs with the University of Queensland.

AstraZeneca rose 1.5%. The European healthcare sector index () jumped 0.9%.

The STOXX 600 index () was 0.8% higher by 0709 GMT, with Frankfurt shares () leading gains after rising 1%.

Shares of insurers (), banks () and automakers () climbed more than 1% in early trading.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close